113642-05-0 Usage
Description
Methyl 3-Bromo-4-Ethylbenzoate is a versatile chemical compound characterized by a benzene ring with a methyl group, a bromine atom, and an ethyl group attached to it. It is recognized for its reactivity and capacity to participate in various chemical transformations, which makes it an indispensable building block in the synthesis of more complex molecules. Its properties and adaptability have established it as a widely utilized compound across the chemical industry.
Uses
Used in Organic Synthesis:
Methyl 3-Bromo-4-Ethylbenzoate is used as a building block in organic synthesis for its ability to form more complex molecules, which are essential in the development of new pharmaceuticals and materials.
Used in Pharmaceutical Research:
In pharmaceutical research, Methyl 3-Bromo-4-Ethylbenzoate is utilized as a key intermediate, contributing to the creation of innovative drugs and therapeutic agents.
Used in Agrochemical Production:
Methyl 3-Bromo-4-Ethylbenzoate is employed as an intermediate in the production of agrochemicals, playing a crucial role in the development of new pesticides and other agricultural chemicals.
Used in Specialty Chemicals Industry:
Methyl 3-Bromo-4-Ethylbenzoate is also used in the production of specialty chemicals, where its unique properties and reactivity are harnessed to create specific chemical products for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 113642-05-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,3,6,4 and 2 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 113642-05:
(8*1)+(7*1)+(6*3)+(5*6)+(4*4)+(3*2)+(2*0)+(1*5)=90
90 % 10 = 0
So 113642-05-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H11BrO2/c1-3-7-4-5-8(6-9(7)11)10(12)13-2/h4-6H,3H2,1-2H3
113642-05-0Relevant articles and documents
Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole and related heterocycles
Burgeson, James R.,Moore, Amy L.,Gharaibeh, Dima N.,Larson, Ryan A.,Cerruti, Natasha R.,Amberg, Sean M.,Hruby, Dennis E.,Dai, Dongcheng
, p. 750 - 756 (2013/02/25)
A series of potent arenavirus inhibitors sharing a benzimidazole core were previously reported by our group. SAR studies were expanded beyond the previous analysis, which involved the attached phenyl rings and methylamino linker portion, to include modifications focused on the benzimidazole core. These changes included the introduction of various substituents to the bicyclic benzimidazole ring system along with alternate core heterocycles. Many of the analogs containing alternate nitrogen-based bicyclic ring systems were found to retain antiviral potency compared to the benzimidazole series from which we derived our lead compound, ST-193. In fact, 21h, built on an imidazopyridine core, possessed a near tenfold increase in potency against Lassa virus pseudotypes compared to ST-193. As found with the benzimidazole series, broad-spectrum arenavirus activity was also observed for a number of the analogs discovered during this study.
SUBSTITUTED PIPERAZINES, (1,4) DIASZEPINES, AND 2,5-DIAZABICYCLO (2.2.1) HEPTANES AS HISTAMINE H1 AND/OR H3 ANTAGONISTS OR HISTAMINE H3 REVERSE ANTAGONISTS
-
Page 25-26, (2008/06/13)
The present invention relates to novel piperazine and azepine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurodegenerative disorders including Alzheimer's disease.
